Biochemicals

Items 501-510 of 994

per page
Set Descending Direction
  1. Isorhamnetin
    CAS  480-19-3
    CDX-I0174
    CDX-I0174-M0055 mg
    CHF 95.00
    Isorhamnetin
  2. Isotretinoin
    CAS  4759-48-2
    AG-CR1-3709
    AG-CR1-3709-M05050 mg
    CHF 30.00
    AG-CR1-3709-M250250 mg
    CHF 120.00
    Isotretinoin
  3. IWR-1-endo
    CAS  1127442-82-3
    AG-CR1-3581
    AG-CR1-3581-M0055 mg
    CHF 110.00
    IWR-1-endo
  4. Ixazomib citrate [MLN9708]
    CAS  1239908-20-3
    AG-CR1-3671
    AG-CR1-3671-M0011 mg
    CHF 40.00
    AG-CR1-3671-M0055 mg
    CHF 120.00
    AG-CR1-3671-M02525 mg
    CHF 420.00
    Ixazomib citrate [MLN9708]
  5. Ixazomib [MLN2238]
    CAS  1072833-77-2
    AG-CR1-3670
    AG-CR1-3670-M0011 mg
    CHF 45.00
    AG-CR1-3670-M0055 mg
    CHF 180.00
    AG-CR1-3670-M02525 mg
    CHF 540.00
    Ixazomib [MLN2238]
  6. Jak/Src Inhibitor 1 . hydrochloride
    CAS  1332329-27-7 (parent)
    AG-CR1-3647
    AG-CR1-3647-M0011 mg
    CHF 150.00
    Jak/Src Inhibitor 1 . hydrochloride
  7. Jasplakinolide (high purity)
    CAS  102396-24-7
    AG-CN2-0037
    AG-CN2-0037-C05050 µg
    CHF 260.00
    AG-CN2-0037-C100100 µg
    CHF 420.00
    Jasplakinolide (high purity)
  8. JNJ-38158471
    CAS  951151-97-6
    SYN-1133
    SYN-1133-M0011 mg
    CHF 270.00
    SYN-1133-M0055 mg
    CHF 546.00
    SYN-1133-M01010 mg
    CHF 766.00
    SYN-1133-M05050 mgINQ
    SYN-1133-M100100 mgINQ
    JNJ-38158471
  9. JNJ-38877605
    CAS  943540-75-8
    SYN-1047
    SYN-1047-M0011 mg
    CHF 128.00
    SYN-1047-M0055 mg
    CHF 184.00
    SYN-1047-M01010 mg
    CHF 298.00
    SYN-1047-M05050 mg
    CHF 1'064.00
    SYN-1047-M100100 mgINQ
    JNJ-38877605
  10. JNJ-7706621
    CAS  443797-96-4
    SYN-1048
    SYN-1048-M0011 mg
    CHF 177.00
    SYN-1048-M0055 mg
    CHF 298.00
    SYN-1048-M01010 mg
    CHF 504.00
    SYN-1048-M05050 mg
    CHF 1'185.00
    SYN-1048-M100100 mgINQ
    JNJ-7706621

Items 501-510 of 994

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.